HRMECs treated with SUZ12 siRNA demonstrate increased miR-200b expression, decreased VEGF expression and decreased endothelial branching. by Michael Anthony Ruiz (726055)

“…<p><b>A,B:</b> Gene knockdown of EZH2 and SUZ12 was confirmed by qPCR. <b>C,D:</b> In HRMECs transfected with EZH2 siRNA in HG, miR-200b and VEGF were not significantly different from HG+control siRNA but decreased compared to NG+control siRNA. …”

AM251 reverses TGF-β1-dependent decreases in E-cadherin expression. by Tomoyo Yoshinaga (3391553)

Decreased number of anastomoses in BCAS-treated mice. by Jill M. Roberts (4760685)

The ratio of standard deviation to mean dose (SD/mean) decreases with neuronal dose. by Murat Alp (781371)

Ifit2 deficiency results in decreased neuroinflammation upon RSA59 infection. by Jayasri Das Sarma (652473)

PRV-induced infertility is caused by decreased P4 level. by Bing-Qian Su (8616981)

The combination of LPS and PFC caused faster clot initiation and decreased clot strength. by Heather F. Pidcoke (9023789)

“…Clot initiation is accelerated with PFC by 4 days. Both SAL-PFC12 and LPS-PFC3 are significantly decreased from BL levels (*, p < .05); SAL-PFC12 is significantly different from SAL-SAL control (†, p < .05). …”

Female ρ1 (−/−) mice showed decreased ethanol conditioned taste aversion. by Yuri A. Blednov (396502)

Anesthetics differentially decrease cilia-driven particle transport speed (PTS). by Ghulam Murtaza (2559319)

“…<b>(D)</b> Avertin® (1 mM) decreased PTS. N = 5 tracheas from 5 animals. <b>(E)</b> Avertin® (4 mM) robustly decreased basal PTS and ATP could not induce increase in PTS. …”

Inactivation of the spermidine transporter led to decreased transcription of T3SS genes. by Lian Zhou (272766)

Level of phosphorylated syndecan-4 regulates NFAT activation and is decreased by calcineurin. by Alexandra V. Finsen (193861)

<i>SIRT6</i> Minor Allele Genotype Is Associated with >5-Year Decrease in Lifespan in an Aged Cohort by Mindi J. TenNapel (679433)

Trending decrease in Slfn family RNA expression from the splenic tissue of VC-Slfn3KO mice. by Emilie E. Vomhof-DeKrey (6900677)

WNT3 decreases GCP proliferation by inhibiting SHH dependent gene transcription. by Sandrine L. Anne (489755)

“…<p>(<i>A</i>) WNT3 decreased proliferation of GCPs by 40.3± 5.0% of the control (Con) (n=3) as measured by [³H]-Thymidine incorporation assay. …”

Decrease in oxidative phosphorylation yield in presence of butyrate in perfused liver isolated from fed rats-0 by Jean-Louis Gallis (2926)

“…</p><p></p>b) phosphocholine; (c) intracellular inorganic phosphate (Pi); (d) glycerol-3-phosphoryl ethanolamine and glycerol-3-phosphorylcholine; (e) nucleoside-5'-triphosphates (γNTP) and diphosphates (βNTP); (f) α-NTP and α-NDP; (g) nicotinamide adenine dinucleotide; (h) uridine-5'-diphosphoglucose; (i) βNTP. …”

CC-1⁺ immunostained cell numbers decrease by 2 days after TBI and return to control levels by 5 weeks. by Krista A. Dent (709531)

“…Panels show contralateral (Contra) and ipsilateral (Ipsi) external capsule (EC) at (A,B) 2 days (2d), (C,D) 2 weeks (2w) and (E,F) 5 weeks (5w) (G) In the external capsule numbers of CC-1⁺ oligodendrocytes were decreased by 2d after injury, remained decreased at 2 weeks and returned to normal levels by 5 weeks. …”

GCase activity is significantly decreased in the brain and liver of the homozygous <i>GBA1</i> D409V KI mouse model at 4, 8, and 12 months of age. by Nicole K. Polinski (10947787)

“…In whole brain homogenate (A,C) and liver homogenate (B,D), GCase activity is significantly decreased in the <i>GBA1</i> D409V KI homozygous (HOM) mice as compared to C57Bl/6 wild type (WT) mice (n = 7/group). …”

Inhibition of ALK4/5/7 decreases Sertoli cell proliferation in E12.5 fetal testes. by Denise C. Miles (218867)

Image12_Repression of enhancer RNA PHLDA1 promotes tumorigenesis and progression of Ewing sarcoma via decreasing infiltrating T‐lymphocytes: A bioinformatic analysis.TIF by Runzhi Huang (7428713)

“…Meanwhile, enhancers transcript non-coding RNAs, known as enhancer RNAs (eRNAs), which may serve as potential diagnosis markers and therapeutic targets in Ewing sarcoma.…”

VPS34 inhibition decreases intracellular levels of cholesteryl-esters, blocks cholesterol uptake and enhances lysosomal degradation of LDLR. by Marek J. Kobylarz (9292599)